Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jianerkang Medical CoSHSE:603205 +1.38%31 EV-to-FCF is 32.35 as of Jul. 29, 2026, which is 23% below its 10-year median of 41.99. GuruFocus rates SHSE:603205 with a GF Score™ of 31/100. The stock has 3 warning signs investors should review. Among 417 Medical Devices & Instruments companies, Jianerkang Medical Co ranks worse than 63.55% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Jianerkang Medical Co's Enterprise Value is ¥2,423 Mil.
Jianerkang Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥75 Mil. Therefore, Jianerkang Medical Co's EV-to-FCF for today is 32.35.
The historical rank and industry rank for Jianerkang Medical Co's EV-to-FCF or its related term are showing as below:
SHSE:603205'
s EV-to-FCF Range Over the Past 10 Years
Min: 30.44 Med: 41.99 Max: 80.79
Current: 32.52
During the past 7 years, the highest EV-to-FCF of Jianerkang Medical Co was 80.79. The lowest was 30.44. And the median was 41.99.
SHSE:603205's EV-to-FCF is ranked worse than 63.55% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 23.13
vs SHSE:603205: 32.52
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Jianerkang Medical Co (SHSE:603205) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Jianerkang Medical Co's PE Ratio (TTM) for today is calculated as:
Jianerkang Medical Co's share price for today is ¥20.64.
Jianerkang Medical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.710.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603205 vs ISRG, BDX, MDLN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, Jianerkang Medical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jianerkang Medical Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Jianerkang Medical Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Jianerkang Medical Co's EV-to-FCF falls into.
Jianerkang Medical Co's current Enterprise Value is ¥2,423 Mil.
Jianerkang Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥75 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jianerkang Medical Co (SHSE:603205) has a EV-to-FCF of 32.35 as of Jul. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Jianerkang Medical Co and its competitors. This is 23% below median its historical median of 41.99. Over the past decade, Jianerkang Medical Co's EV-to-FCF has ranged from 30.44 to 80.79. According to the industry distribution chart, Jianerkang Medical Co ranks #265 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 63.5%.
Is Jianerkang Medical Co's EV-to-FCF too high?
Jianerkang Medical Co's current EV-to-FCF of 32.35 is 23% below median its 10-year median of 41.99. Over the past 10 years, this metric has ranged from a low of 30.44 to a high of 80.79. The Medical Devices & Instruments industry median EV-to-FCF is 23.13. Jianerkang Medical Co's value of 32.35 is 39.9% above this industry median. Based on the distribution chart, Jianerkang Medical Co ranks #265 out of 417 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Jianerkang Medical Co has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Jianerkang Medical Co's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Jianerkang Medical Co ranks #265 out of 417 companies for EV-to-FCF. This places Jianerkang Medical Co in the lower half of its industry. The industry median EV-to-FCF is 23.13. Jianerkang Medical Co's value of 32.35 is 39.9% above this benchmark. Historically, Jianerkang Medical Co's own EV-to-FCF has ranged from 30.44 to 80.79 over the past decade. While the company's 10-year median is 41.99 vs. the industry median of 23.13, Jianerkang Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.13, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jianerkang Medical Co's current EV-to-FCF of 32.35 is 39.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Jianerkang Medical Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jianerkang Medical Co's current EV-to-FCF is 32.35, which is 23% below median its own 10-year median of 41.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jianerkang Medical Co stock overvalued right now?
Jianerkang Medical Co (SHSE:603205) has a current EV-to-FCF of 32.35. The current EV-to-FCF is 32.35, which is 23% below median its 10-year median of 41.99 and 39.9% above the Medical Devices & Instruments industry median of 23.13. Jianerkang Medical Co's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Jianerkang Medical Co (SHSE:603205), the current EV-to-FCF is 32.35 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jianerkang Medical Co Ltd is engaged in research and development, production and sales of disposable medical devices such as medical dressings and disinfection and hygiene products.
31GF Score
Get the complete analysis for SHSE:603205
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603205 has been successfully added to your 
